Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.0900
+0.0050 (5.88%)
Dec 10, 2025, 3:24 PM EST
-47.06%
Market Cap1.25M
Revenue (ttm)n/a
Net Income (ttm)-342.81K
Shares Out13.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,699
Average Volume22,428
Open0.0850
Previous Close0.0850
Day's Range0.0850 - 0.0900
52-Week Range0.0700 - 0.4500
Beta1.44
RSI50.34
Earnings DateMar 5, 2026

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.